Mobile Health Messaging for HIV/AIDS
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on helping you stick to your existing HIV treatment plan.
What data supports the effectiveness of the Mobile Health Messaging application treatment for HIV/AIDS?
Is mobile health messaging safe for use in humans?
How is the Mobile Health Messaging application treatment different from other HIV/AIDS treatments?
The Mobile Health Messaging application is unique because it uses text messages to remind patients to take their medication and attend appointments, which can improve adherence to treatment and overall health outcomes. Unlike traditional treatments that focus solely on medication, this approach leverages mobile technology to support behavior change and enhance patient engagement.1291011
What is the purpose of this trial?
The purpose of this study is:1. To develop a new mobile health (mHealth) system that will send text messages to remind both pregnant and non-pregnant women with HIV to adhere to their treatment plan (like keeping appointments, fillings prescriptions, and taking their medication) and address individual barriers to HIV care (like stigma, medical mistrust and resilience).2. The intervention will also include patient navigation and motivational interviewing2) Investigators also want to see if the mHealth system is feasible, easily accepted and if it will impact patient health in a positive way.
Research Team
Lunthita M Duthely, Ed.D.
Principal Investigator
University of Miami
Eligibility Criteria
This trial is for women over 18 with HIV who have missed appointments, had a detectable viral load, or haven't taken their meds as prescribed. They must be currently in care or recently back in care and own a working cell phone. It's not for men, those under 18, cognitively impaired individuals unable to consent, or without a cell phone.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive mobile health messaging and patient navigation to improve treatment adherence and address barriers to HIV care
Follow-up
Participants are monitored for changes in clinic attendance, stigma, medical mistrust, and resilience
Treatment Details
Interventions
- Mobile Health Messaging application
- Standard of Care Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Miami
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator